You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company is moving its production of the GAD65 protein, the active substance in its diabetes vaccine Diamyd, from abroad to Umeå, Sweden. The new unit is around 1,000 square meters in size and contains clean rooms, laboratories and offices. Today, the unit has six employees, including proteinAlready a subscriber…
A new project seeks to build on the cluster’s strengths by positioning it as a global centre for microbiome research. The Microbiome Signature Project aims to strengthen entry into the Greater Copenhagen region’s research environment within microbiome research through enhancing collaboration Already a subscriber Login You have read all your…
Allergan has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam. Together, the two companies will evaluate the combination to treat serious infections caused by metallo βlactamase MBL-Already a subscriber Login You have read all your free articles, to…
Just before Christmas, the Norwegian company announced that it has received support from Oslo County of 1.950 million NOK. The funding will support optimization of the synthesis of our two lead compounds, APC148 and APC247. The program will define the optimal characteristics of the substances thaAlready a subscriber Login You…
